SCHEMBL13015262

SCHEMBL13015262

NC(=O)c1occc1C(O)c1ccc(F)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
ALDH1A1 P00352 3/20 0.37
HPGD P15428 2/20 0.37
USP2 O75604 1/20 0.37
HTT P42858 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
EPHX1 P07099 1/20 0.35
AOC3 Q16853 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35
TSHR P16473 1/20 0.35
AHR P35869 1/20 0.35
MAPK10 P53779 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ALPG P10696 2/20 0.34
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL753760 0.87 ALDH1A1 (0.42) LMNASMN1; SMN2ALDH1A1HPGDUSP2
SCHEMBL6633897 0.71 MAPK14 (0.45) ALDH1A1MAPT
SCHEMBL2301987 0.71 MAPT (0.38) LMNAALDH1A1MAPTTSHRHSD17B10
SCHEMBL16925396 0.69 BRD4 (0.32) AOC3KMT2AATM
SCHEMBL16097786 0.68
SCHEMBL477477 0.67 EPHX1 (0.48) LMNASMN1; SMN2ALDH1A1HPGDUSP2
SCHEMBL21542545 0.67 EPHX1 (0.48) LMNASMN1; SMN2ALDH1A1HPGDUSP2
SCHEMBL21542539 0.67 EPHX1 (0.48) LMNASMN1; SMN2ALDH1A1HPGDUSP2
SCHEMBL754901 0.67 ALDH1A1 (0.36) ALDH1A1HPGDHTTNPSR1TP53
SCHEMBL597442 0.66 IDO1 (0.46) LMNASMN1; SMN2ALDH1A1AOC3ALPG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2266958-B1 Antiviral agent SHIONOGI & CO (JP) 2017-03-15 EP disclosed
EP-2266958-A1 Antiviral agent SHIONOGI & CO., LTD. (JP) 2010-12-29 EP disclosed